• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
Irish America

Irish America

        • Who We Are
          • About Us
          • Irish America Team
        • The Lists
          • Business 100
          • Hall of Fame
          • Health and Life Sciences 50
          • Wall Street 50
        • Highlights
          • History
          • In This Issue
          • Music
          • Politics
          • Sports
          • Travel
        • Columns
          • First Word
          • Hibernia
          • Quote Unquote
          • Slainte
          • Those we Lost
          • What are you like?
          • Wild Irish Women
          • Window on The Past
  • Home
  • Who We Are
    • About This Magazine
    • Irish America Team
  • In This Issue
  • Hall of Fame
  • The Lists
    • Business 100
    • Hall of Fame
    • Health and Life Sciences 50
    • Wall Street 50
  • Archives
    • Magazine
    • Highlights
  • Travel
  • Events
Healthcare and Life Sciences 50 – 2016

Kevin Horgan

Dr. Kevin Horgan is a physician scientist in Philadelphia, Pennsylvania. He was born in London, and his parents were natives of Clare and Cork. After attending Crescent College Comprehensive in Limerick he graduated in medicine from University College Cork in 1982. He completed postgraduate medical training at the Johns Hopkins Hospital in Baltimore, the National Cancer Institute in Bethesda, and UCLA in internal medicine, immunology and gastroenterology. After four years on the faculty at UCLA, where he specialized in managing inflammatory bowel disease, he joined the pharmaceutical industry at Merck Research Laboratories. There he led the development of the groundbreaking drug Emend for the prevention of nausea and vomiting associated with cancer chemotherapy. A decade after its approval in 2003, no similar drug has been successfully developed.

Since then, Kevin has contributed to the development of several novel therapies and diagnostics for inflammatory bowel disease and Alzheimer’s. His immunology research provided important early support for the development of three approved medications for multiple sclerosis, psoriasis, Crohn’s disease, and ulcerative colitis. After working with several small biotechnology companies on novel immunotherapies and diagnostics, he is now a Global Medical Lead at Astra-Zeneca in the rapidly developing area of immunooncology.

Previous Next

Footer

Follow Us

  • Facebook
  • Instagram
  • LinkedIn
  • Twitter
  • YouTube

Subscribe

  • Subscribe
  • Give a Gift
  • Newsletter
  • Customer Service

Additional

  • Advertise
  • Contact
  • Terms of Use & Privacy Policy

Copyright © 2022 · IrishAmerica Child Theme on Genesis Framework · WordPress · Log in